Home-administered Transcranial Direct Current Stimulation (tDCS) Treatment for Depression

The University of New South Wales1 site in 1 country34 target enrollmentMarch 2016

ConditionsMajor Depression

Overview

Phase: Not Applicable
Intervention: Not specified
Conditions: Major Depression
Sponsor: The University of New South Wales
Enrollment: 34
Locations: 1
Primary Endpoint: Montgomery Asberg Depression Rating Scale for Depression (MADRS)
Status: Completed
Last Updated: 7 years ago

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

Transcranial Direct Current Stimulation (tDCS) is a novel non-invasive brain stimulation treatment that is effective with no significant side effects. It can potentially be self-administered by patients in their own homes with remote monitoring, substantially reducing treatment costs and increasing accessibility, including to remote areas. This study will evaluate the feasibility and efficacy of home-administered tDCS treatment for depression.

Registry

clinicaltrials.gov

Start Date

March 2016

End Date

July 2018

Last Updated

7 years ago

Study Type

Interventional

Study Design

Single Group

Sex

All

Investigators

Sponsor

The University of New South Wales

Responsible Party

Principal Investigator

Colleen Loo

Professor

The University of New South Wales

Eligibility Criteria

Inclusion Criteria

•Subject meets criteria for a DSM-IV Major Depressive Episode, lasting more than 4 weeks
•Total MADRS score ≥ 20

Exclusion Criteria

•Diagnosis of any DSM-IV psychotic disorder
•History of drug or alcohol abuse or dependence in the preceding 3 months
•High suicide risk
•Clinically defined neurological disorder or insult
•Metal in the cranium or skull defects
•Skin lesions on the scalp (e.g. cuts, abrasions, rashes) at the proposed electrode sites
•Pregnancy